John William Wulf - 12 Nov 2025 Form 4 Insider Report for agilon health, inc. (AGL)

Role: Director
Signature: /s/ Mimi Yang, as Attorney-in-Fact
Issuer symbol: AGL
Transactions as of: 12 Nov 2025
Net transactions value: +$50,941
Form type: 4
Filing time: 30 Jan 2026, 19:30:58 UTC
Previous filing: 30 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wulf John William	Director	C/O AGILON HEALTH, INC., 440 POLARIS PARKWAY, SUITE 550, WESTERVILLE	/s/ Mimi Yang, as Attorney-in-Fact	30 Jan 2026	0001856345

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGL	Common Stock	Purchase	$50,941	+81,000	+28%	$0.6289	365,857	12 Nov 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.6251 to $0.6321, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F2	Includes restricted stock units.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.6251 to $0.6321, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Includes restricted stock units.